The prevalence of metabolic syndrome and metabolically healthy obesity in Europe: A collaborative analysis of ten large cohort studies

BMC Endocrine Disorders

Volumn 14, Issue , 2014, Pages

  van Vliet Ostaptchouk, Jana V ^a   Nuotio, Marja Liisa ^b,c   Slagter, Sandra N ^a   Doiron, Dany ^d   Fischer, Krista ^e   Foco, Luisa ^f   Gaye, Amadou ^g   Gögele, Martin ^f   Heier, Margit ^h   Hiekkalinna, Tero ^b,c   Joensuu, Anni ^b,c   Newby, Christopher ^g   Pang, Chao ^a   Partinen, Eemil ^e   Reischl, Eva ^h   Schwienbacher, Christine ^f   Tammesoo, Mari Liis ^e   Swertz, Morris A ^a   Burton, Paul ^g   Ferretti, Vincent ⁱ   Fortier, Isabel ^d   Giepmans, Lisette ^a   Harris, Jennifer R ^j   Hillege, Hans L ^a   Holmen, Jostein ^k   Jula, Antti ^c   Kootstra Ros, Jenny E ^a   Kvaløy, Kirsti ^k   Holmen, Turid L ^k   Männistö, Satu ^c   Metspalu, Andres ^e   Midthjell, Kristian ^k   Murtagh, Madeleine J ^g   Peters, Annette ^h   Pramstaller, Peter P ^f,l,m   Saaristo, Timo ⁿ   Salomaa, Veikko ^c   Stolk, Ronald P ^a   Uusitupa, Matti ^o   van der Harst, Pim ^a   van der Klauw, Melanie M ^a   Waldenberger, Melanie ^h   Perola, Markus ^b,c,e   Wolffenbuttel, Bruce H R ^a   more..

^a UNIVERSITY MEDICAL CENTER GRONINGEN   (Netherlands)

^b UNIVERSITY OF HELSINKI   (Finland)

^c NATIONAL PUBLIC HEALTH INSTITUTE   (Finland)

^d RESEARCH INSTITUTE OF THE MCGILL UNIVERSITY HEALTH CENTRE   (Canada)

^e UNIVERSITY OF TARTU   (Estonia)

^f University of Lubeck   (Italy)

^g UNIVERSITY OF BRISTOL   (United Kingdom)

^h INSTITUTE OF EPIDEMIOLOGY   (Germany)

ⁱ ONTARIO INSTITUTE FOR CANCER RESEARCH   (Canada)

^j NORWEGIAN INSTITUTE OF PUBLIC HEALTH   (Norway)

^k NORWEGIAN UNIVERSITY OF SCIENCE AND TECHNOLOGY   (Norway)

^l Central Hospital   (Italy)

^m UNIVERSITY OF LÜBECK   (Germany)

ⁿ Finnish Diabetes Association   (Finland)

^o KUOPIO UNIVERSITY HOSPITAL   (Finland)

more..

Author keywords

Cardiovascular disease; Harmonization; Metabolic syndrome; Metabolically healthy; Obesity

Indexed keywords

EID: 84893193652     PISSN: None     EISSN: 14726823     Source Type: Journal    
DOI: 10.1186/1472-6823-14-9     Document Type: Article

References (60)

1. Swinburn BA, Sacks G, Hall KD, McPherson K, Finegood DT, Moodie ML, et al. The global obesity pandemic: shaped by global drivers and local environments. Lancet 2011, 378:804-814. 10.1016/S0140-6736(11)60813-1, 21872749.
2. Berghofer A, Pischon T, Reinhold T, Apovian CM, Sharma AM, Willich SN. Obesity prevalence from a European perspective: a systematic review. BMC Public Health 2008, 8:200. 10.1186/1471-2458-8-200, 2441615, 18533989.
3. Rabin BA, Boehmer TK, Brownson RC. Cross-national comparison of environmental and policy correlates of obesity in Europe. Eur J Public Health 2007, 17:53-61. 10.1093/eurpub/ckl073, 16751632.
4. Freedman DS. Obesity - United States, 1988-2008. MMWR Surveill Summ 2011, 60(Suppl):73-77.
5. Ogden CL, Carroll MD, Kit BK, Flegal KM. Prevalence of obesity in the United States, 2009-2010. NCHS Data Brief 2012, 1-8.
6. Finucane MM, Stevens GA, Cowan MJ, Danaei G, Lin JK, Paciorek CJ, et al. National, regional, and global trends in body-mass index since 1980: systematic analysis of health examination surveys and epidemiological studies with 960 country-years and 9.1 million participants. Lancet 2011, 377:557-567. 10.1016/S0140-6736(10)62037-5, 21295846.
7. Kelly T, Yang W, Chen CS, Reynolds K, He J. Global burden of obesity in 2005 and projections to 2030. Int J Obes (Lond) 2008, 32:1431-1437. 10.1038/ijo.2008.102, 18607383.
8. Mokdad AH, Ford ES, Bowman BA, Dietz WH, Vinicor F, Bales VS, et al. Prevalence of obesity, diabetes, and obesity-related health risk factors, 2001. JAMA 2003, 289:76-79.
9. Canoy D, Boekholdt SM, Wareham N, Luben R, Welch A, Bingham S, et al. Body fat distribution and risk of coronary heart disease in men and women in the european prospective investigation into cancer and nutrition in norfolk cohort: a population-based prospective study. Circulation 2007, 116:2933-2943. 10.1161/CIRCULATIONAHA.106.673756, 18071080.
10. Pischon T, Nothlings U, Boeing H. Obesity and cancer. Proc Nutr Soc 2008, 67:128-145. 10.1017/S0029665108006976, 18412987.
11. Pischon T, Boeing H, Hoffmann K, Bergmann M, Schulze MB, Overvad K, et al. General and abdominal adiposity and risk of death in Europe. N Engl J Med 2008, 359:2105-2120. 10.1056/NEJMoa0801891, 19005195.
12. Whitlock G, Lewington S, Sherliker P, Clarke R, Emberson J, Halsey J, et al. Body-mass index and cause-specific mortality in 900 000 adults: collaborative analyses of 57 prospective studies. Lancet 2009, 373:1083-1096. 10.1016/S0140-6736(09)60318-4, 2662372, 19299006.
13. Bijlsma JW, Berenbaum F, Lafeber FP. Osteoarthritis: an update with relevance for clinical practice. Lancet 2011, 377:2115-2126. 10.1016/S0140-6736(11)60243-2, 21684382.
14. Primeau V, Coderre L, Karelis AD, Brochu M, Lavoie ME, Messier V, et al. Characterizing the profile of obese patients who are metabolically healthy. Int J Obes (Lond) 2011, 35:971-981. 10.1038/ijo.2010.216, 20975726.
15. Grundy SM, Cleeman JI, Daniels SR, Donato KA, Eckel RH, Franklin BA, et al. Diagnosis and management of the metabolic syndrome: an american heart association/national heart, lung, and blood institute scientific statement. Circulation 2005, 112:2735-2752. 10.1161/CIRCULATIONAHA.105.169404, 16157765.
16. Eckel RH, Alberti KG, Grundy SM, Zimmet PZ. The metabolic syndrome. Lancet 2010, 375:181-183. 10.1016/S0140-6736(09)61794-3, 20109902.
17. Stefan N, Kantartzis K, Machann J, Schick F, Thamer C, Rittig K, et al. Identification and characterization of metabolically benign obesity in humans. Arch Intern Med 2008, 168:1609-1616. 10.1001/archinte.168.15.1609, 18695074.
18. Wildman RP, Muntner P, Reynolds K, McGinn AP, Rajpathak S, Wylie-Rosett J, et al. The obese without cardiometabolic risk factor clustering and the normal weight with cardiometabolic risk factor clustering: prevalence and correlates of 2 phenotypes among the US population (NHANES 1999-2004). Arch Intern Med 2008, 168:1617-1624. 10.1001/archinte.168.15.1617, 18695075.
19. Velho S, Paccaud F, Waeber G, Vollenweider P, Marques-Vidal P. Metabolically healthy obesity: different prevalences using different criteria. Eur J Clin Nutr 2010, 64:1043-1051. 10.1038/ejcn.2010.114, 20628408.
20. Kantartzis K, Machann J, Schick F, Rittig K, Machicao F, Fritsche A, et al. Effects of a lifestyle intervention in metabolically benign and malign obesity. Diabetologia 2011, 54:864-868. 10.1007/s00125-010-2006-3, 21174075.
21. Pajunen P, Kotronen A, Korpi-Hyovalti E, Keinanen-Kiukaanniemi S, Oksa H, Niskanen L, et al. Metabolically healthy and unhealthy obesity phenotypes in the general population: the FIN-D2D Survey. BMC Public Health 2011, 11:754. 10.1186/1471-2458-11-754, 3198943, 21962038.
22. Geetha L, Deepa M, Anjana RM, Mohan V. Prevalence and clinical profile of metabolic obesity and phenotypic obesity in Asian Indians. J Diabetes Sci Technol 2011, 5:439-446. 3125940, 21527117.
23. Denis GV, Obin MS. 'Metabolically healthy obesity': origins and implications. Mol Aspects Med 2013, 34:59-70. 10.1016/j.mam.2012.10.004, 3583231, 23068072.
24. Pataky Z, Bobbioni-Harsch E, Golay A. Open questions about metabolically normal obesity. Int J Obes (Lond) 2010, 34(Suppl 2):S18-S23.
25. Phillips CM, Dillon C, Harrington JM, McCarthy VJ, Kearney PM, Fitzgerald AP, et al. Defining metabolically healthy obesity: role of dietary and lifestyle factors. PLoS One 2013, 8:e76188. 10.1371/journal.pone.0076188, 3798285, 24146838.
26. Hamer M, Stamatakis E. Metabolically healthy obesity and risk of all-cause and cardiovascular disease mortality. J Clin Endocrinol Metab 2012, 97:2482-2488. 10.1210/jc.2011-3475, 3387408, 22508708.
27. Hamer M, Stamatakis E. Low-dose physical activity attenuates cardiovascular disease mortality in men and women with clustered metabolic risk factors. Circ Cardiovasc Qual Outcomes 2012, 5:494-499. 10.1161/CIRCOUTCOMES.112.965434, 22619275.
28. Kuk JL, Ardern CI. Are metabolically normal but obese individuals at lower risk for all-cause mortality?. Diabetes Care 2009, 32:2297-2299. 10.2337/dc09-0574, 2782994, 19729521.
29. Fortier I, Burton PR, Robson PJ, Ferretti V, Little J, L'Heureux F, et al. Quality, quantity and harmony: the DataSHaPER approach to integrating data across bioclinical studies. Int J Epidemiol 2010, 39:1383-1393. 10.1093/ije/dyq139, 2972444, 20813861.
30. Harris JR, Burton P, Knoppers BM, Lindpaintner K, Bledsoe M, Brookes AJ, et al. Toward a roadmap in global biobanking for health. Eur J Hum Genet 2012, 20:1105-1111. 10.1038/ejhg.2012.96, 3477856, 22713808.
31. Doiron D, Ferretti V, Burton P, Marcon Y, Gaye A, Wolffenbuttel BHR, et al. Data harmonization and federated analysis of population-based studies: the BioSHaRE project. Emerging Themes Epidemiology 2013, 10:12.
32. Metspalu A. Estonian genome project-before the take-off and take-off. Bioinformatics 2002, 18(Suppl 2):S152. 10.1093/bioinformatics/18.suppl_2.S152, 12385997.
33. Inouye M, Kettunen J, Soininen P, Silander K, Ripatti S, Kumpula LS, et al. Metabonomic, transcriptomic, and genomic variation of a population cohort. Mol Syst Biol 2010, 6:441. 3018170, 21179014.
34. Aromaa A, Koskinen S. Baseline results of the health 2000 health examination survey: health and functional capacity in Finland. Publications of the National Public Health Institute B12/2004. 2004, 1-148. Helsinki: National Public Health Institute, Aromaa A, Koskinen S.
35. Wichmann HE, Gieger C, Illig T. KORA-gen-resource for population genetics, controls and a broad spectrum of disease phenotypes. Gesundheitswesen 2005, 67(Suppl 1):S26-S30.
36. Pattaro C, Marroni F, Riegler A, Mascalzoni D, Pichler I, Volpato CB, et al. The genetic study of three population microisolates in South Tyrol (MICROS): study design and epidemiological perspectives. BMC Med Genet 2007, 8:29. 1913911, 17550581.
37. Stolk RP, Rosmalen JG, Postma DS, de Boer RA, Navis G, Slaets JP, et al. Universal risk factors for multifactorial diseases: lifeLines: a three-generation population-based study. Eur J Epidemiol 2008, 23:67-74. 10.1007/s10654-007-9204-4, 18075776.
38. Pinto-Sietsma SJ, Janssen WM, Hillege HL, Navis G, de ZD, de Jong PE. Urinary albumin excretion is associated with renal functional abnormalities in a nondiabetic population. J Am Soc Nephrol 2000, 11:1882-1888.
39. Krokstad S, Langhammer A, Hveem K, Holmen T, Midthjell K, Stene T, et al. Cohort profile: the HUNT study, norway. Int J Epidemiol 2013, 42:968-977. 10.1093/ije/dys095, 22879362.
40. Power C, Elliott J. Cohort profile: 1958 British birth cohort (National Child Development Study). Int J Epidemiol 1958, 2006(35):34-41.
41. World Health Organization (WHO) Obesity: preventing and managing the global epidemic. Report of a WHO consultation. World Health Organ Tech Rep Ser 2000, 894:i-253. World Health Organization (WHO).
42. Expert Panel on Detection Evaluation, and Treatment of High Blood Cholesterol in Adults Executive summary of the third report of the national cholesterol education program (NCEP) expert panel on detection, evaluation, and treatment of high blood cholesterol in adults (adult treatment panel III). JAMA 2001, 285:2486-2497. 10.1001/jama.285.19.2486, 11368702, Expert Panel on Detection Evaluation, and Treatment of High Blood Cholesterol in Adults.
43. Sidhu D, Naugler C. Fasting time and lipid levels in a community-based population: a cross-sectional study. Arch Intern Med 2012, 172:1707-1710. 10.1001/archinternmed.2012.3708, 23147400.
44. Sundquist J, Johansson SE, Sundquist K. Levelling off of prevalence of obesity in the adult population of Sweden between 2000/01 and 2004/05. BMC Public Health 2010, 10:119. 10.1186/1471-2458-10-119, 2847975, 20214805.
45. Lissner L, Sohlstrom A, Sundblom E, Sjoberg A. Trends in overweight and obesity in Swedish schoolchildren 1999-2005: has the epidemic reached a plateau?. Obes Rev 2010, 11:553-559.
46. Micciolo R, Di Francisco V, Fantin F, Canal L, Harris TB, Bosello O, et al. Prevalence of overweight and obesity in Italy (2001-2008): is there a rising obesity epidemic?. Ann Epidemiol 2010, 20:258-264. 10.1016/j.annepidem.2010.01.006, 20149969.
47. Rokholm B, Baker JL, Sorensen TI. The levelling off of the obesity epidemic since the year 1999-a review of evidence and perspectives. Obes Rev 2010, 11:835-846. 10.1111/j.1467-789X.2010.00810.x, 20973911.
48. Grundy SM. Metabolic syndrome pandemic. Arterioscler Thromb Vasc Biol 2008, 28:629-636. 10.1161/ATVBAHA.107.151092, 18174459.
49. Onat A. Metabolic syndrome: nature, therapeutic solutions and options. Expert Opin Pharmacother 2011, 12:1887-1900. 10.1517/14656566.2011.585462, 21756201.
50. Onat A, Ceyhan K, Basar O, Erer B, Toprak S, Sansoy V. Metabolic syndrome: major impact on coronary risk in a population with low cholesterol levels-a prospective and cross-sectional evaluation. Atherosclerosis 2002, 165:285-292. 10.1016/S0021-9150(02)00236-8, 12417279.
51. Nichols M, Townsend N, Scarborough P, Rayner M. Cardiovascular disease in Europe: epidemiological update. Eur Heart J 2013, 34:3028-3034. 10.1093/eurheartj/eht356, 24014390.
52. Cornier MA, Dabelea D, Hernandez TL, Lindstrom RC, Steig AJ, Stob NR, et al. The metabolic syndrome. Endocr Rev 2008, 29:777-822. 10.1210/er.2008-0024, 18971485.
53. Karelis AD, Messier V, Brochu M, Rabasa-Lhoret R. Metabolically healthy but obese women: effect of an energy-restricted diet. Diabetologia 2008, 51:1752-1754. 10.1007/s00125-008-1038-4, 18504546.
54. Criqui MH. Response bias and risk ratios in epidemiologic studies. Am J Epidemiol 1979, 109:394-399.
55. Heath GW, Parra DC, Sarmiento OL, Andersen LB, Owen N, Goenka S, et al. Evidence-based intervention in physical activity: lessons from around the world. Lancet 2012, 380:272-281. 10.1016/S0140-6736(12)60816-2, 22818939.
56. Gordon T, Kannel WB, Dawber TR, McGee D. Changes associated with quitting cigarette smoking: the Framingham study. Am Heart J 1975, 90:322-328. 10.1016/0002-8703(75)90320-8, 1163424.
57. Cena H, Fonte ML, Turconi G. Relationship between smoking and metabolic syndrome. Nutr Rev 2011, 69:745-753. 10.1111/j.1753-4887.2011.00446.x, 22133198.
58. Williamson DF, Madans J, Anda RF, Kleinman JC, Giovino GA, Byers T. Smoking cessation and severity of weight gain in a national cohort. N Engl J Med 1991, 324:739-745. 10.1056/NEJM199103143241106, 1997840.
59. Chiolero A, Faeh D, Paccaud F, Cornuz J. Consequences of smoking for body weight, body fat distribution, and insulin resistance. Am J Clin Nutr 2008, 87:801-809.
60. Sun K, Liu J, Ning G. Active smoking and risk of metabolic syndrome: a meta-analysis of prospective studies. PLoS One 2012, 7:e47791. 10.1371/journal.pone.0047791, 3474781, 23082217.